Glivo M 0.2mg/500mg/80mg Tablet
Marketer
Daxia Healthcare
Salt Composition
Voglibose (0.2mg) + Metformin (500mg) + Gliclazide (80mg)
Overview Glivo M 0.2mg/500mg/80mg Tablet
DiabetaComb 0.2mg/500mg/80mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. These tablets help regulate blood glucose in diabetic patients. DiabetaComb 0.2mg/500mg/80mg tablets should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular meals and carry a fast-acting glucose source (sugary foods or juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, vomiting, diarrhea, abdominal pain, headache, swelling (edema), blurred vision, and bone fractures. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your physician of any prior heart conditions before initiating treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.
Primary Ingredients of Glivo M 0.2mg/500mg/80mg Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Glivo M 0.2mg/500mg/80mg Tablet
Managing type 2 diabetes
Major Benefits of Glivo M 0.2mg/500mg/80mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Glivo M 0.2mg/500mg/80mg Tablet should be administered with a meal.
Common Side effects of Glivo M 0.2mg/500mg/80mg Tablet:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Glivo M 0.2mg/500mg/80mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Glivo M 0.2mg/500mg/80mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
How Glivo M 0.2mg/500mg/80mg Tablet works:
Each Glivo M tablet (0.2mg/500mg/80mg) contains a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glivo M 0.2mg/500mg/80mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glivo M 0.2mg/500mg/80mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Mothers who are breastfeeding should exercise caution when using Glivo M 0.2mg/500mg/80mg tablets. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glivo M 0.2mg/500mg/80mg tablets cautiously, potentially requiring dosage modification. Consult your physician. Glivo M 0.2mg/500mg/80mg tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glivo M 0.2mg/500mg/80mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Low initial doses are typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glivo M 0.2mg/500mg/80mg Tablet :
NA
Facts to Know About Glivo M 0.2mg/500mg/80mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently